Wei‐Chun Chen

1.1k total citations
48 papers, 793 citations indexed

About

Wei‐Chun Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Wei‐Chun Chen has authored 48 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Physiology. Recurrent topics in Wei‐Chun Chen's work include Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Asthma and respiratory diseases (4 papers). Wei‐Chun Chen is often cited by papers focused on Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Asthma and respiratory diseases (4 papers). Wei‐Chun Chen collaborates with scholars based in Taiwan, China and United States. Wei‐Chun Chen's co-authors include Yu‐Hao Lin, Wei‐Lung Mao, Chien‐Tsung Wang, Bo Li, Pengwen Hou, Haris Imam Karim Fathurrahman, Jin‐Ching Lee, Xiao Chang, Xue Chen and Sheng-Hsien Chen and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Analytical Chemistry.

In The Last Decade

Wei‐Chun Chen

44 papers receiving 780 citations

Peers

Wei‐Chun Chen
Kang‐Dae Lee South Korea
Yan Song China
Jinxi Li China
Jong Soo Kim South Korea
Wei‐Chun Chen
Citations per year, relative to Wei‐Chun Chen Wei‐Chun Chen (= 1×) peers Katharina Kaiser

Countries citing papers authored by Wei‐Chun Chen

Since Specialization
Citations

This map shows the geographic impact of Wei‐Chun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Chun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Chun Chen more than expected).

Fields of papers citing papers by Wei‐Chun Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Chun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Chun Chen. The network helps show where Wei‐Chun Chen may publish in the future.

Co-authorship network of co-authors of Wei‐Chun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Chun Chen. A scholar is included among the top collaborators of Wei‐Chun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Chun Chen. Wei‐Chun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ou, Yvonne, Wei‐Chun Chen, Wangta Liu, et al.. (2025). Sofalcone Suppresses Dengue Virus Replication by Activating Heme Oxygenase-1-Mediated Antiviral Interferon Responses. International Journal of Molecular Sciences. 26(13). 5921–5921.
3.
Sun, Kai, et al.. (2024). Hybrid statistical and machine-learning approach to hearing-loss identification based on an oversampling technique. Computers in Biology and Medicine. 185. 109539–109539. 1 indexed citations
4.
Huang, Wei‐Chun, Chih‐Yu Chen, Wei‐Chih Liao, et al.. (2024). Comparison of Budesonide/formoterol versus Fluticasone furoate/vilanterol as maintenance and reliever therapy for asthma control: a real-world observational study. BMC Pulmonary Medicine. 24(1). 374–374. 1 indexed citations
5.
Liu, W., et al.. (2024). Progerin Inhibits the Proliferation and Migration of Melanoma Cells by Regulating the Expression of Paxillin. OncoTargets and Therapy. Volume 17. 227–242. 3 indexed citations
6.
Chen, Wei‐Chun, Ming-Jay Deng, Ping‐Yu Liu, Chun-Chi Lai, & Yu‐Hao Lin. (2023). A framework for real-time vehicle counting and velocity estimation using deep learning. Sustainable Computing Informatics and Systems. 40. 100927–100927. 8 indexed citations
7.
Chen, Wei‐Chun, Jie Ruan, Fan Deng, et al.. (2023). Vemurafenib induces a noncanonical senescence-associated secretory phenotype in melanoma cells which promotes vemurafenib resistance. Heliyon. 9(7). e17714–e17714. 4 indexed citations
8.
Chen, Chia‐Hung, Chih‐Yen Tu, Wei‐Chih Liao, et al.. (2021). P12‐5: Correlation between bispectral index (BIS) and modified observer's assessment of alertness/sedation (MOAA/S) score in flexible bronchoscopy. Respirology. 26(S3). 416–416.
9.
Huang, Wei‐Chun, Chih‐Yu Chen, Wei‐Chih Liao, et al.. (2021). A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease. International Journal of COPD. Volume 16. 1555–1568. 4 indexed citations
10.
Chen, Wei‐Chun, Ping‐Yu Liu, Chun-Chi Lai, & Yu‐Hao Lin. (2021). Identification of environmental microorganism using optimally fine-tuned convolutional neural network. Environmental Research. 206. 112610–112610. 11 indexed citations
11.
Li, Chia-Hsiang, Wei‐Chun Chen, Chih‐Yen Tu, et al.. (2021). The Risk of Tuberculosis Infection in Non-dialysis Chronic Kidney Disease Patients. Frontiers in Medicine. 8. 715010–715010. 6 indexed citations
12.
Hu, Xiaoting, et al.. (2020). <p>Overexpression of Progerin Results in Impaired Proliferation and Invasion of Non-Small Cell Lung Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 2629–2642. 6 indexed citations
13.
Liao, Wei‐Chih, Wei‐Chun Chen, Te‐Chun Hsia, et al.. (2020). When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment. International Journal of COPD. Volume 15. 3375–3384. 4 indexed citations
14.
Shen, Te‐Chun, WEN-SHIN CHANG, Te‐Chun Hsia, et al.. (2019). <p>Contribution of programmed cell death 6 genetic variations, gender, and smoking status to lung cancer</p>. OncoTargets and Therapy. Volume 12. 6237–6244. 8 indexed citations
15.
Hong, Chun-Fu, et al.. (2018). Construction of diagnosis system and gene regulatory networks based on microarray analysis. Journal of Biomedical Informatics. 81. 61–73. 2 indexed citations
16.
Chen, Wei‐Chun, et al.. (2016). Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway. PLoS ONE. 11(3). e0152236–e0152236. 44 indexed citations
17.
Imbriglio, Jason E., Daniel A. DiRocco, Subharekha Raghavan, et al.. (2010). The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME properties. Bioorganic & Medicinal Chemistry Letters. 21(9). 2721–2724. 13 indexed citations
19.
Chen, Sheng-Hsien, Chia‐Yu Chang, Wei‐Chun Chen, et al.. (2009). Premarin stimulates estrogen receptor-α to protect against traumatic brain injury in male rats*. Critical Care Medicine. 37(12). 3097–3106. 25 indexed citations
20.
Shen, Kun‐Hung, et al.. (2008). PREMARIN CAN ACT VIA ESTROGEN RECEPTORS TO RESCUE MICE FROM HEATSTROKE-INDUCED LETHALITY. Shock. 30(6). 668–674. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026